Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Antonio Jirillo, Michaela Stefani, Federica Vascon & Sara Lonardi. (2008) Adjuvant Systemic Chemotherapy with 5-Fluorouracil and Leucovorin in Colon Cancer: A Monoinstitutional Institutional Experience. Immunopharmacology and Immunotoxicology 30:2, pages 235-242.
Read now
Read now
Articles from other publishers (11)
Zhiqiang Zhang, Anning Li, Xingqi Min, Qunqun Zhang, Jun Yang, Guo Chen, Meijuan Zou, Wei Sun & Gang Cheng. (2021)
An ROS-sensitive tegafur-PpIX-heterodimer-loaded
in situ
injectable thermosensitive hydrogel for photodynamic therapy combined with chemotherapy to enhance the tegafur-based treatment of breast cancer
. Biomaterials Science 9:1, pages 221-237.
Crossref
Crossref
Wen-Ting Lv, Xiao-Xu Liu, Xia-Lin Dai, Xiang-Tian Long & Jia-Mei Chen. (2020) A 5-fluorouracil–kaempferol drug–drug cocrystal: a ternary phase diagram, characterization and property evaluation. CrystEngComm 22:46, pages 8127-8135.
Crossref
Crossref
Xia-Lin Dai, Chao Wu, Jin-Hui Li, Lian-Chao Liu, Xin He, Tong-Bu Lu & Jia-Mei Chen. (2020)
Modulating the solubility and pharmacokinetic properties of 5-fluorouracil
via
cocrystallization
. CrystEngComm 22:21, pages 3670-3682.
Crossref
Crossref
Yu-Chieh Lee, Chia-Yu Su, Yuan-Feng Lin, Chun-Mao Lin, Chih-Yeu Fang, Yen-Kuang Lin, Michael Hsiao & Chi-Long Chen. (2017) Lysosomal acid phosphatase 2 is an unfavorable prognostic factor but is associated with better survival in stage II colorectal cancer patients receiving chemotherapy. Oncotarget 8:7, pages 12120-12132.
Crossref
Crossref
Joanna Szkandera, Gudrun Absenger, Martin Pichler, Michael Stotz, Tanja Langsenlehner, Hellmut Samonigg, Wilfried Renner & Armin Gerger. (2013) Association of common gene variants in vitamin D modulating genes and colon cancer recurrence. Journal of Cancer Research and Clinical Oncology 139:9, pages 1457-1464.
Crossref
Crossref
S. Khoei, M. Azarian, S. Khoee & A R Mahdavian. (2012) Evaluation of the cytotoxic effect of PLGA coated iron oxide nanoparticles as 5-fluorouracil carrier on DU 145 human prostate carcinoma cell line. Evaluation of the cytotoxic effect of PLGA coated iron oxide nanoparticles as 5-fluorouracil carrier on DU 145 human prostate carcinoma cell line.
Kara L. Vine, Julie M. Locke, John B. Bremner, Stephen G. Pyne & Marie Ranson. (2010) Selective targeting of 2′-deoxy-5-fluorouridine to urokinase positive malignant cells in vitro. Bioorganic & Medicinal Chemistry Letters 20:9, pages 2908-2911.
Crossref
Crossref
MARK SCHNEIDER, MOTOKO TANAKA-NOZAKI, SHUNJI KATO & BRUNHILDE BLÖMEKE. (2010) Influence of 5-fluorouracil on ferredoxin reductase mRNA splice variants in colorectal carcinomas. Oncology Letters 1:2, pages 351-354.
Crossref
Crossref
Jong Hwan Sung, Anjali Dhiman & Michael L. Shuler. (2009) A Combined Pharmacokinetic–Pharmacodynamic (PK–PD) Model for Tumor Growth in the Rat with UFT Administration. Journal of Pharmaceutical Sciences 98:5, pages 1885-1904.
Crossref
Crossref
Manuel B. Braga-Neto, Cirle A. Warren, Reinaldo B. Oriá, Manuel S. Monteiro, Andressa A. S. Maciel, Gerly A. C. Brito, Aldo A. M. Lima & Richard L. Guerrant. (2008) Alanyl-Glutamine and Glutamine Supplementation Improves 5-Fluorouracil-Induced Intestinal Epithelium Damage In Vitro. Digestive Diseases and Sciences 53:10, pages 2687-2696.
Crossref
Crossref
Antonello Di Paolo, Monica Lencioni, Federica Amatori, Samantha Di Donato, Guido Bocci, Cinzia Orlandini, Marianna Lastella, Francesca Federici, Mauro Iannopollo, Alfredo Falcone, Sergio Ricci, Mario Del Tacca & Romano Danesi. (2008) 5-Fluorouracil Pharmacokinetics Predicts Disease-free Survival in Patients Administered Adjuvant Chemotherapy for Colorectal Cancer. Clinical Cancer Research 14:9, pages 2749-2755.
Crossref
Crossref